Market Business Insights Point-of-Care Molecular Diagnostics Market
Request Sample Buy Now

Table Of Contents

  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
    4. Currency
    5. Key Target Audience
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Infection
      2. Market Attractiveness Analysis By Cardiovascular
      3. Market Attractiveness Analysis By Oncology
      4. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. XXXXXXXXXXXXXXXXXXXXXXX
      2. XXXXXXXXXXXXXXXXXXXXXXXXXXXXX
      3. XXXXXXXXXXXXXXXXXXXXX
    3. Restraints
      1. XXXXXXXXXXXXXXXXXXXXXXXXXXXX
    4. Opportunities
      1. XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
  6. Global Market Analysis and Forecast, By Infection
    1. Segment Overview
    2. HIV
    3. Hepatitis
    4. Respiratory
    5. Sexually transmitted diseases
  7. Global Market Analysis and Forecast, By Cardiovascular
    1. Segment Overview
    2. Cardiac markers
    3. Lipid profile
    4. Troponin
  8. Global Market Analysis and Forecast, By Oncology
    1. Segment Overview
    2. Tumor markers
    3. Genetic testing
  9. Global Point-of-Care Molecular Diagnostics Market Analysis and Forecast, By Regional Analysis
    1. Segment Overview
    2. North America
      1. US
      2. Canada
      3. Mexico
    3. Europe
      1. UK
      2. Germany
      3. Italy
      4. Russia
      5. France
      6. Rest of Europe
    4. Asia-Pacific
      1. India
      2. Japan
      3. China
      4. South Korea
      5. Australia
      6. Rest of Asia-Pacific (APAC)
    5. Latin America
      1. Brazil
    6. Middle East & Africa
      1. Saudi Arabia
      2. U.A.E.
      3. South Africa
      4. Rest of Middle East and Africa (MEA)
  10. Global Point-of-Care Molecular Diagnostics Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in Global Point-of-Care Molecular Diagnostics Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Product Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  11. Company Profiles
    1. Abbott Laboratories
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2. Danaher Corporation
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3. Hologic Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4. QIAGEN N.V.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5. Roche Diagnostics
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis
  1. Global Market, By Infection, 2018-2028 (USD Million)
  2. Global Market, By Cardiovascular, 2018-2028 (USD Million)
  3. Global Market, By Oncology, 2018-2028 (USD Million)
  4. Global Secure Messaging, Point-of-Care Molecular Diagnostics Market, By Region, 2018-2028 (USD Million)
  5. Global Web Portal, Point-of-Care Molecular Diagnostics Market, By Region, 2018-2028 (USD Million)
  6. Global Private, Point-of-Care Molecular Diagnostics Market, By Region, 2018-2028 (USD Million)
  7. Global Public,Point-of-Care Molecular Diagnostics Market, By Region, 2018-2028 (USD Million)
  8. North America Market, By Infection, 2018-2028 (USD Million)
  9. North America Market, By Cardiovascular, 2018-2028 (USD Million)
  10. North America Market, By Oncology, 2018-2028 (USD Million)
  11. U.S. Market, By Infection, 2018-2028 (USD Million)
  12. U.S. Market, By Cardiovascular, 2018-2028 (USD Million)
  13. U.S. Market, By Oncology, 2018-2028 (USD Million)
  14. Canada Market, By Infection, 2018-2028 (USD Million)
  15. Canada Market, By Cardiovascular, 2018-2028 (USD Million)
  16. Canada Market, By Oncology, 2018-2028 (USD Million)
  17. Mexico Market, By Infection, 2018-2028 (USD Million)
  18. Mexico Market, By Cardiovascular, 2018-2028 (USD Million)
  19. Mexico Market, By Oncology, 2018-2028 (USD Million)
  20. Europe Market, By Infection, 2018-2028 (USD Million)
  21. Europe Market, By Cardiovascular, 2018-2028 (USD Million)
  22. Europe Market, By Oncology, 2018-2028 (USD Million)
  23. U.K. Market, By Infection, 2018-2028 (USD Million)
  24. U.K. Market, By Cardiovascular, 2018-2028 (USD Million)
  25. U.K. Market, By Oncology, 2018-2028 (USD Million)
  26. Germany Market, By Infection, 2018-2028 (USD Million)
  27. Germany Market, By Cardiovascular, 2018-2028 (USD Million)
  28. Germany Market, By Oncology, 2018-2028 (USD Million)
  29. Italy Market, By Infection, 2018-2028 (USD Million)
  30. Italy Market, By Cardiovascular, 2018-2028 (USD Million)
  31. Italy Market, By Oncology, 2018-2028 (USD Million)
  32. France Market, By Infection, 2018-2028 (USD Million)
  33. France Market, By Cardiovascular, 2018-2028 (USD Million)
  34. France Market, By Oncology, 2018-2028 (USD Million)
  35. Russia Market, By Infection, 2018-2028 (USD Million)
  36. Russia Market, By Cardiovascular, 2018-2028 (USD Million)
  37. Russia Market, By Oncology, 2018-2028 (USD Million)
  38. Asia-Pacific Market, By Infection, 2018-2028 (USD Million)
  39. Asia-Pacific Market, By Cardiovascular, 2018-2028 (USD Million)
  40. Asia-Pacific Market, By Oncology, 2018-2028 (USD Million)
  41. India Market, By Infection, 2018-2028 (USD Million)
  42. India Market, By Cardiovascular, 2018-2028 (USD Million)
  43. India Market, By Oncology, 2018-2028 (USD Million)
  44. Japan Market, By Infection, 2018-2028 (USD Million)
  45. Japan Market, By Cardiovascular, 2018-2028 (USD Million)
  46. Japan Market, By Oncology, 2018-2028 (USD Million)
  47. China Market, By Infection, 2018-2028 (USD Million)
  48. China Market, By Cardiovascular, 2018-2028 (USD Million)
  49. China Market, By Oncology, 2018-2028 (USD Million)
  50. South Korea Market, By Infection, 2018-2028 (USD Million)
  51. South Korea Market, By Cardiovascular, 2018-2028 (USD Million)
  52. South Korea Market, By Oncology, 2018-2028 (USD Million)
  53. Australia Market, By Infection, 2018-2028 (USD Million)
  54. Australia Market, By Cardiovascular, 2018-2028 (USD Million)
  55. Australia Market, By Oncology, 2018-2028 (USD Million)
  56. Latin America Market, By Infection, 2018-2028 (USD Million)
  57. Latin America Market, By Cardiovascular, 2018-2028 (USD Million)
  58. Latin America Market, By Oncology, 2018-2028 (USD Million)
  59. Brazil Market, By Infection, 2018-2028 (USD Million)
  60. Brazil Market, By Cardiovascular, 2018-2028 (USD Million)
  61. Brazil Market, By Oncology, 2018-2028 (USD Million)
  62. Middle East & Africa Market, By Infection, 2018-2028 (USD Million)
  63. Middle East & Africa Market, By Cardiovascular, 2018-2028 (USD Million)
  64. Middle East & Africa Market, By Oncology, 2018-2028 (USD Million)
  65. Saudi Arabia Market, By Infection, 2018-2028 (USD Million)
  66. Saudi Arabia Market, By Cardiovascular, 2018-2028 (USD Million)
  67. Saudi Arabia Market, By Oncology, 2018-2028 (USD Million)
  68. UAE Market, By Infection, 2018-2028 (USD Million)
  69. UAE Market, By Cardiovascular, 2018-2028 (USD Million)
  70. UAE Market, By Oncology, 2018-2028 (USD Million)
  71. South Africa Market, By Infection, 2018-2028 (USD Million)
  72. South Africa Market, By Cardiovascular, 2018-2028 (USD Million)
  73. South Africa Market, By Oncology, 2018-2028 (USD Million)
  1. Global Point-of-Care Molecular Diagnostics Market Segmentation
  2. Global Point-of-Care Molecular Diagnostics Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-Down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Global Market Attractiveness Analysis By Infection
  9. Global Market Attractiveness Analysis By Cardiovascular
  10. Global Market Attractiveness Analysis By Oncology
  11. Global Point-of-Care Molecular Diagnostics Market Attractiveness Analysis ByRegion
  12. Global Point-of-Care Molecular Diagnostics Market: Dynamics
  13. Global Market Share By Infection (2021 & 2028)
  14. Global Market Share By Cardiovascular (2021 & 2028)
  15. Global Market Share By Oncology (2021 & 2028)
  16. Global Point-of-Care Molecular Diagnostics Market Share By Region (2021 & 2028)
  17. Global Point-of-Care Molecular Diagnostics Market Share By Company (2020)
We Accept
Select License
Includes
  • Purchase Report Sections
  • Regional analysis
  • Segmentation analysis
  • Industry outlook
  • Competitive landscape
Latest Reports